Evidence map›Paper›PMID 37556098›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2023

Correction to: SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022).

Rosario García-Campelo, Ivana Sullivan, Edurne Arriola, Amelia Insa, Oscar Juan Vidal, Patricia Cruz-Castellanos, Teresa Morán, Noemí Reguart, Jon Zugazagoitia, Manuel Dómine

Abstract readPublished Erratum
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. SEOM 2022 clinical guidelines.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Rosario García-CampeloDepartment of Medical Oncology, Hospital Universitario A Coruña, Health Research Institute, INIBIC, A Coruña, Spain. ma.rosario.garcia.campelo@sergas.es.ORCID http://orcid.org/0000-0003-2113-1504
Ivana SullivanDepartment of Medical Oncology, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona, Spain.ORCID https://orcid.org/0000-0002-0434-3436
Edurne ArriolaDepartment of Medical Oncology, Hospital del Mar-CIBERONC, Barcelona, Spain.
Amelia InsaDepartmert of Medical Oncology, Hospital Clínico de Valencia, Valencia, Spain.
Oscar Juan VidalDepartment of Medical Oncology, Hospital Universitari i Politécnic La Fe de Valencia, Valencia, Spain.
Patricia Cruz-CastellanosDepartment of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain.
Teresa MoránDepartment of Medical Oncology, Badalona Applied Research Group in Oncology, Catalan Institute of Oncology Badalona, Hospital Universitario Germans Trias i Pujol, Institut Germans Trias i Pujol, Barcelona, Spain.
Noemí ReguartDepartment of Medical Oncology, Hospital Clinic, Barcelona, Spain.
Jon ZugazagoitiaDepartment of Medical Oncology, Tumor Microenvironment and Immunotherapy Research Group, Hospital Universitario 12 de Octubre, Madrid, Health Research Institute Hospital Universitario 12 de Octubre (i+12), H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute, CIBERONC, Madrid, Spain.
Manuel DómineDepartment of Medical Oncology. Hospital, Universitario Fundación Jiménez Díaz, IIS-FJD, Oncohealth Institute, Universidad Autónoma de Madrid, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37556098
PMCPMC10425482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.